Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
PUT
Innodata
INOD
$1.96B
| $305K | ﹤0.01% |
+8,500
| New | +$373K |
|
2577
ECARX Holdings
ECX
$428M
| $304K | ﹤0.01% |
+241,474
| New | +$516K |
|
|
CYBR
2578
PUT
DELISTED
CyberArk
CYBR
| $304K | ﹤0.01% |
900
| – | – |
|
2579
CALL
Qorvo
QRVO
$8.41B
| $304K | ﹤0.01% |
4,200
-13,400
| -76% | -$1.02M |
|
2580
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $304K | ﹤0.01% |
7,068
-375,072
| -98% | -$16.4M |
|
2581
PUT
Lowe's Companies
LOW
$122B
| $303K | ﹤0.01% |
1,300
-23,600
| -95% | -$5.81M |
|
2582
PUT
Inspire Medical Systems
INSP
$1.78B
| $303K | ﹤0.01% |
1,900
-2,500
| -57% | -$452K |
|
2583
BCE
BCE
$22.2B
| $302K | ﹤0.01% |
13,137
-2,357
| -15% | -$55.4K |
|
2584
PUT
Prudential Financial
PRU
$42.3B
| $302K | ﹤0.01% |
+2,700
| New | +$308K |
|
2585
CALL
AstraZeneca
AZN
$259B
| $301K | ﹤0.01% |
2,050
-1,350
| -40% | -$195K |
|
2586
CALL
Credo Technology Group
CRDO
$41.5B
| $301K | ﹤0.01% |
7,500
-23,300
| -76% | -$1.45M |
|
2587
PUT
Charles River Laboratories
CRL
$14.3B
| $301K | ﹤0.01% |
2,000
-300
| -13% | -$50.3K |
|
2588
PUT
Universal Health Services
UHS
$10.4B
| $301K | ﹤0.01% |
1,600
-5,600
| -78% | -$1.02M |
|
2589
Palladyne AI
PDYN
$285M
| $300K | ﹤0.01% |
+51,094
| New | +$415K |
|
2590
PUT
Rigetti Computing
RGTI
$5.46B
| $300K | ﹤0.01% |
+37,900
| New | +$420K |
|
2591
PUT
SM Energy
SM
$8.67B
| $300K | ﹤0.01% |
10,000
+4,800
| +92% | +$172K |
|
2592
PUT
DuPont de Nemours
DD
$18.5B
| $299K | ﹤0.01% |
+3,187
| New | +$311K |
|
2593
PUT
Madrigal Pharmaceuticals
MDGL
$11.8B
| $298K | ﹤0.01% |
+900
| New | +$296K |
|
2594
PUT
Stryker
SYK
$126B
| $298K | ﹤0.01% |
800
-800
| -50% | -$304K |
|
2595
CALL
Brunswick
BC
$5.26B
| $296K | ﹤0.01% |
5,500
+1,600
| +41% | +$100K |
|
2596
Astec Industries
ASTE
$1B
| $296K | ﹤0.01% |
+8,597
| New | +$296K |
|
2597
CALL
Camping World
CWH
$663M
| $296K | ﹤0.01% |
18,300
+7,800
| +74% | +$159K |
|
2598
CALL
Campbell Soup
CPB
$7.2B
| $295K | ﹤0.01% |
+7,400
| New | +$290K |
|
2599
VanEck High Yield Muni ETF
HYD
$4.35B
| $295K | ﹤0.01% |
5,756
+1,114
| +24% | +$57.7K |
|
2600
CALL
Yeti Holdings
YETI
$3.14B
| $295K | ﹤0.01% |
8,900
-5,000
| -36% | -$181K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.